Kirsten Tryde Macklon

ORCID: 0000-0001-8830-513X · 4 papers in corpus
other 2025
Human reproduction open ·doi:10.1093/hropen/hoaf068

STUDY QUESTION: What is the return rate for the use of ovarian tissue cryopreserved for fertility preservation prior to gonadotoxic treatment? SUMMARY ANSWER: The return rate for the use of ovarian tissue cryopreserved for fertility preser…

review 2023
Human reproduction open ·doi:10.1093/hropen/hoad012

Although a wealth of data has been published regarding fertility preservation (FP) in women with malignant diseases who receive gonadotoxic treatment, the role of FP in non-malignant conditions has been studied to a much lesser extent. Thes…

observational 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01633-4

PURPOSE: To evaluate the association between anti-Müllerian hormone (AMH) and follicle density in infertile women with diminished ovarian reserve (DOR) versus women with normal ovarian reserve? METHODS: Case-control study comparing follicl…

meta-analysis 2017
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13154

INTRODUCTION: Endometriomas are present in up to 44% of all women with endometriosis and have a detrimental effect on fertility. However, it is controversial whether endometriomas should be surgically removed before assisted reproduction te…